Industry S Science News
European scientists face uncertainty as pandemic recovery fund winds down
More than €55 billion from EU fund has gone to research and innovation, but researchers worry those investments will not be sustained
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Industry S Science News
More than €55 billion from EU fund has gone to research and innovation, but researchers worry those investments will not be sustained
Regulatory
Clinical Trials Arena
Bright Minds’ stock dropped by 52% after announcing the partial clinical hold on the Phase II seizure trial. The post FDA puts partial hold on Bright Minds’ Phase II seizure study appeared first on Clinical Trials Arena.
Industry P Pharmafile
EnteroBiotix has appointed Dr Murray Stewart, former Chief Medical Officer at GSK and Rhythm Pharmaceuticals, to its Board of Directors. Stewart has also served as Head of Research and Development at Novelion Therapeutics. During his time at Rhythm, he helped secure the first US…
Clinical
Clinical Trials Arena
By closing off the left atrial appendage (LAA), Abbott's Amulet 360 is designed to reduce stroke risk in AFib patients unsuitable for blood-thinning medication regimens. The post Abbott’s Amulet 360 demonstrates strong one-year outcomes in AFib patients appeared first on Clinical…
Clinical
Clinical Trials Arena
InventisBio's nomelcitinib is one of several TYK2 inhibitors currently in late-stage development for plaque psoriasis globally. The post InventisBio’s psoriasis pill secures Phase III win as TYK2 market heats up appeared first on Clinical Trials Arena.
Regulatory A Applied Clinical Trials
In today’s ACT Brief, we examine what changes when AI is embedded across clinical operations, why faster trial data isn’t yet producing faster decisions, and how FDA granted accelerated approval to a therapy for a rare airway disease.
Industry P Pharmaceutical Executive
Dr. Jay Lalezari of CytoDyn explains why Leronlimab’s circulating tumor DNA results in colorectal cancer represent a unique, mechanism-specific proof of concept rather than a broader template.
Manufacturing P pharmaphorum
Merck charts course out of CDMO business with Lonza sale Phil.Taylor Tue, 03/11/2026 - 10:47
Software P Paired Ends
Most claims about LLMs don’t hold up a few months after publication.
Industry P pharmaphorum
Radiology has been optimising the wrong metric Nicole.Raleigh Tue, 03/11/2026 - 10:30
Software M Mac in Chem
The next Cambridge Cheminformatics Network Meeting is 11 November 2026, 4pm UK time at Cambridge Crystallographic Data Centre, Cambridge, UK and Online (Hybrid Mode)
Software O Open Targets
We introduce Open Targets Mira, our new clinical mining pipeline released in March 2026, how we envision the integration of this drug-indication evidence with the rest of the Open Targets Platform, and how you can use Mira yourself to extend our analyses with your own research.
Industry
European Biotechnology
Denmark-based BioInnovation Institute (BII) is expanding its European CardioMetabolic Bridge to Munich and Berlin. Backed by up to DKK 450 million (around €60 million) from the Novo Nordisk Foundation, the initiative aims to accelerate the translation of academic research into me…
Clinical
Clinical Trials Arena
Tiziana Life Sciences has reported that its Phase IIa INFORM-MS study of intranasal foralumab for na-SPMS met its dual primary endpoints. The post Tiziana’s Phase IIa trial of foralumab meets dual endpoints in na-SPMS appeared first on Clinical Trials Arena.
Funding
Pharmaceutical Technology
Lonza has entered an agreement for the acquisition of five US CDMO sites from Merck KGaA, bringing 1,100 employees into Lonza's workforce.
Regulatory P pharmaphorum
uniQure set for May FDA verdict on Huntington's gene therapy Phil.Taylor Tue, 03/11/2026 - 09:59
Industry
European Biotechnology
AstraZeneca is cutting costs and early cancer programs, while Ayrmid is pursuing another struggling U.S. drugmaker. This week’s six updates also include a Huntington’s gene therapy review, mixed MS data and new plans for vaccines and hypertension treatment. The post AstraZeneca t…
Clinical
Clinical Trials Arena
Teva Pharmaceuticals has announced plans to halt a Phase II clinical trial evaluating emrusolmin (TEV-'286) to treat adults with MSA, after an interim analysis found the study was unlikely to meet its primary efficacy endpoint. The post Teva to halt Phase II MSA therapy trial aft…
Industry P pharmaphorum
LEAP HR: Life Sciences Europe Sara.Scarpinati Tue, 03/11/2026 - 09:39
Industry
Pharmaceutical Technology
Bavarian Nordic has secured a four-year contract from the UK Government to supply its MVA-BN vaccine, used for the prevention of mpox and smallpox.
Clinical
MHRA
The Health Research Authority (HRA) has published the findings from its pilot on researchers and sponsors of clinical trials and clinical investigations developing and submitting an Inclusion and Diversity Plan.
Industry B BioTechniques
Curious about the latest advances in immunology research? We’ve got you covered: these five recent studies cover major breakthroughs in vaccine development, allergy research and our understanding of the immune system. A step toward self-amplifying vaccines Self-amplifying RNA (sa…
Clinical P Pharmafile
By Sanjeev Sachdeva Safeguarding patient health is the foremost responsibility of the pharmaceutical sector. While every medicine undergoes rigorous clinical evaluation before it is approved, the true safety of a drug only fully emerges once it enters the real-world, intera…
Funding P Pharmafile
US medical technology company Stryker is investing approximately US$400m (£300m) in UK surgical robotics developer CMR Surgical, alongside securing an exclusive option to acquire the remaining equity in the business. The agreement also gives Stryker exclusive US commercial agency…
Manufacturing
Labiotech
Explore how integrated infrastructure can help advanced therapy supply chains reduce fragmentation, maintain continuity, and support global growth. The post Why global expansion is changing the shape of the ATMP supply chain appeared first on Labiotech.eu. © Labiotech UG and Labi…
Industry P pharmaphorum
Rational Based Drug Design Summit Europe Sara.Scarpinati Tue, 03/11/2026 - 08:56
Software M Mac in Chem
A reader recently highlighted ChemDraft (https://chemdraft.ai). A lightweight, open-source (Apache-2.0) chemical drawing app for macOS and Windows. It is built around local files and a
Manufacturing
MedTech Dive
The Sanford, North Carolina, facility will become the company's first manufacturing facility for injectable contrast media in the U.S.
Industry P pharmaphorum
Solution Spotlight: BrandPRO Biopharma Nicole.Raleigh Tue, 03/11/2026 - 08:00
Industry P Pharmaceutical Commerce
Webinar Date/Time: Thu, Nov 12, 2026 2:00 PM EST
Software S Science News
Some researchers get top tools for next to nothing—but others pay out of pocket or go without
Industry F FDA Law Blog
By Sara W. Koblitz —
Industry S Science News
Potentially massive illicit trade could be endangering the animals and undermining Indigenous artists
Clinical
BioCentury
BIOCENTURY | PRODUCT DEVELOPMENTESMO’S FIRST-IN-HUMAN SIGNALS, AUCHINCLOSS’ PROPOSAL & COINS REACTION — A BIOCENTURY PODCASTPlus: Woodcock on making individualized rare disease therapies commercially viable
Industry N Nature Reviews Bioengineering
Industry
Nature Biotechnology
Industry N Nature Medicine
Industry N Nature Biomedical Engineering
Industry N Nature Medicine
Clinical N Nature Medicine